Sign In
Buy KMDA
$7.14
+0.0400 (+0.563%)
At Close: Jul 31, 2026
REHOVOT, Israel and HOBOKEN, N.J., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed product
REHOVOT, Israel, and HOBOKEN, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indic
Kamada Provides Corporate Update on its Israel Operations
07:37am, Tuesday, 10'th Oct 2023
REHOVOT, Israel, and HOBOKEN, N.J., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed produc
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Kamada Announces Shareholder Approval and Planned Closing of $60 Million Private Placement with FIMI Opportunity Funds
07:00am, Wednesday, 30'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed product
Kamada Reports Strong Second Quarter and First Half 2023 Financial Results; Reiterates 2023 Revenue and Profitability Guidance
07:00am, Wednesday, 16'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed product
Kamada to Announce Second Quarter and First Half Ended June 30, 2023 Financial Results and Host Conference Call on August 16, 2023
07:00am, Wednesday, 09'th Aug 2023
REHOVOT, Israel and HOBOKEN, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indica
Kamada: Deep Dive Following FIMI Placement, Rate Buy
05:10am, Wednesday, 21'st Jun 2023
Kamada Ltd. has potential catalysts for growth, capital attraction and regulatory tailwinds. The company's valuation appears attractive, with forward estimates suggesting a possible re-rating. Key ris
Kamada Ltd. (KMDA) Q1 2023 Earnings Call Transcript
01:21pm, Wednesday, 24'th May 2023
Kamada Ltd. (NASDAQ:KMDA ) Q1 2023 Results Earnings Conference Call May 24, 2023 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors, LLC Amir London - Chief Executive
Kamada to Announce First Quarter 2023 Financial Results and Host Conference Call on May 24, 2023
07:00am, Wednesday, 17'th May 2023
REHOVOT, Israel and HOBOKEN, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicat
Kamada Ltd. (KMDA) Q4 2022 Earnings Call Transcript
04:07pm, Wednesday, 15'th Mar 2023
Kamada Ltd. (NASDAQ:KMDA ) Q4 2022 Earnings Conference Call March 15, 2023 8:30 AM ET Company Participants Troy Williams - LifeSci Advisors Amir London - CEO Chaime Orlev - CFO Conference Call Partici
New Strong Buy Stocks for November 28th
09:02am, Monday, 28'th Nov 2022
KMDA, SLCA and FTNT have been added to the Zacks Rank #1 (Strong Buy) List on November 28, 2022.
Kamada Ltd. (KMDA) Q3 2022 Earnings Call Transcript
10:35am, Tuesday, 22'nd Nov 2022
Kamada Ltd. (NASDAQ:KMDA ) Q3 2022 Earnings Conference Call November 22, 2022 8:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Amir London - Chief Executive Officer Chaime Orlev - Chief Fi
Kamada (KMDA) Q3 Earnings and Revenues Top Estimates
09:47am, Tuesday, 22'nd Nov 2022
Kamada (KMDA) delivered earnings and revenue surprises of 433.33% and 8.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kamada Ltd. (KMDA) CEO Amir London on Q2 2022 Results - Earnings Call Transcript
01:58pm, Wednesday, 17'th Aug 2022
Kamada Ltd. (NASDAQ:KMDA ) Q2 2022 Earnings Conference Call August 17, 2022 8:30 AM ET Company Representatives Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Bob Yedid -
